Abstract
The widespread comorbidity among psychiatric disorders (PDs) demonstrated in epidemiological studies1–5 is mirrored by non-zero, positive genetic correlations from large scale genetic studies6–10. We employed several strategies to uncover pleiotropic SNPs, genes and biological pathways7,8 underlying this genetic covariance. First, we conducted cross-trait meta-analysis on 12 PDs to identify pleiotropic SNPs. However, the majority of meta-analytic signal was driven by only one or a few PDs, hampering interpretation and joint biological characterization of the meta-analytic signal. Next, we performed pairwise comparisons of PDs on the SNP, gene, genomic region, gene-set, tissue-type, and cell-type level. Substantial overlap was observed, but mainly among pairs of PDs, and mainly at less stringent p-value thresholds. Only heritability enrichment for “conserved genomic regions” and “nucleotide diversity” was significant for multiple (9 out of 12) PDs. Overall, identification of shared biological mechanisms remains challenging due to variation in power and genetic architecture between PDs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by NWO Gravitation program BRAINSCAPES: A Roadmap from Neurogenetics to Neurobiology (NWO: 024.004.012). The analyses were carried out on the Genetic Cluster Computer, which is financed by the Netherlands Scientific Organization (NWO: 480-05-003), by the VU University, Amsterdam, the Netherlands, and by the Dutch Brain Foundation, and is hosted by the Dutch National Computing and Networking Services SurfSARA. This research has been conducted using the UK Biobank resource under application number 16406.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available genome-wide summary statistics on 12 psychiatric disorders that have originally been conducted using human data. Genome-wide summary statistics on attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, anorexia nervosa, depression, Tourette syndrome, obsessive-compulsive disorder, schizophrenia and alcohol use disorder are publicly available for download at the psychiatric genomics consortium website: https://www.med.unc.edu/pgc/download-results/. Genome-wide summary statistics on insomnia is available at: https://ctg.cncr.nl/software/summary_statistics/. Genome-wide summary statistics on post-traumatic stress disorder and anxiety disorder was obtained from the million veteran program (https://www.research.va.gov/mvp/) and transferred through correspondence with Daniel Levey (daniel.levey{at}yale.edu).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵§ These authors jointly supervised this work
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
